Stonnington Group, LLC Eli Lilly & CO Transaction History

Stonnington Group, LLC

$381 Million
Q1 2023

A detailed history of Stonnington Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Stonnington Group, LLC holds 4,465 shares of LLY stock, worth $4.08 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

4,465

Previous 7,466 40.2%

Holding current value

$4.08 Million

Previous $2.73 Million 43.87%

% of portfolio

0.4%

Previous 0.77%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 14, 2023	SELL	$310.63 - $364.82 $932,200 - $1.09 Million	-3,001 Reduced 40.2%	4,465 $1.53 Million
Q4 2022 Jan 11, 2023	BUY	$321.55 - $374.67 $323,479 - $376,918	1,006 Added 15.57%	7,466 $0
Q3 2022 Oct 20, 2022	BUY	$296.48 - $337.87 $318,716 - $363,210	1,075 Added 19.96%	6,460 $2.13 Million
Q2 2022 Jul 08, 2022	BUY	$278.73 - $327.27 $884,967 - $1.04 Million	3,175 Added 143.67%	5,385 $1.77 Million
Q1 2022 Apr 12, 2022	SELL	$234.69 - $291.66 $3.81 Million - $4.74 Million	-16,235 Reduced 88.02%	2,210 $683,000

Q4 2021 Jan 12, 2022	BUY	$224.85 - $279.04 $3.55 Million - $4.41 Million	15,810 Added 600.0%	18,445 $4.84 Million
Q4 2021 Jan 12, 2022	BUY	$224.85 - $279.04 $120,294 - $149,286	535 Added 25.48%	2,635 $691,000
Q3 2021 Oct 12, 2021	SELL	$221.6 - $272.71 $28,143 - $34,634	-127 Reduced 5.7%	2,100 $491,000
Q2 2021 Jul 09, 2021	SELL	$180.55 - $233.54 $550,677 - $712,297	-3,050 Reduced 57.8%	2,227 $528,000
Q1 2021 May 21, 2021	BUY	$164.32 - $212.72 $867,116 - $1.12 Million	5,277 New	5,277 $1.02 Million

Others Institutions Holding LLY

# of Institutions

3,721

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $869B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonnington Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonnington Group, LLC with notifications on news.

Account

Stonnington Group, LLC Eli Lilly & CO Transaction History